General MedicationsORALStandard
ARIPIPRAZOLE
ARIPIPRAZOLE
Standard Dose
20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ARIPIPRAZOLE is listed in Drugs@FDA under application 090165 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 20MG Sponsor SQUARE PHARMS Submission history Latest submission status date: 2025-01-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview ARIPIPRAZOLE is listed in Drugs@FDA under application 090165 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 20MG Sponsor SQUARE PHARMS Submission history Latest submission status date: 2025-01-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.